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Abstract
Background: Breast cancer is prevalent and has high cure rates. The resultant increase in numbers 
of breast cancer survivors (BCS) may overwhelm the current oncology workforce in years to come. 
We postulate that primary care physicians (PCPs) could play an expanded role in comanaging 
survivors, provided they are given the appropriate tools and training to do so.
Objective: To explore the perspectives of PCPs towards managing BCS in a community-based 
shared-care programme with oncologists.
Methods: Eleven focus groups and six in-depth interviews were conducted with seventy PCPs 
recruited by purposive sampling. All sessions were audio-recorded, transcribed verbatim and 
coded by three independent investigators. Thematic data analysis was performed and the coding 
process facilitated by NVivo 12.
Results: Majority of PCPs reported currently limited roles in managing acute and non-cancer 
issues, optimizing comorbidities and preventive care. PCPs aspired to expand their role to include 
cancer surveillance, risk assessment and addressing unmet psychosocial needs. PCPs preferred 
to harmonize cancer survivorship management of their primary care patients who are also BCS, 
with defined role distinct from oncologists. Training to understand the care protocol, enhancement 
of communication skills, confidence and trust were deemed necessary. PCPs proposed selection 
criteria of BCS and adequacy of their medical information; increased consultation time; contact 
details and timely access to oncologists (if needed) in the shared-care programme.
Conclusions: PCPs were willing to share the care of BCS with oncologists but recommended role 
definition, training, clinical protocol, resources and access to oncologist’s consultation to optimize 
the programme implementation.
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Introduction
According to Globocan estimates, the worldwide incidence of cancer 
is predicted to increase from 18.1 million in 2018 to 29.5 million 
by 2040 (1). The increase in incidence, coupled with improved cure 
rates has resulted in the burgeoning population of cancer survivors 
(2,3). This increasing trend may overwhelm the current oncology 
workforce if survivorship care remains specialist-centric, as is the 
case in many countries today.
Singapore is a high-income country situated in Asia and is also 
facing rising cancer incidence where the estimated lifetime risk for 
developing cancer is one in every four to five people (4). Breast cancer 
is the most common cancer among Singaporean women, and many 
survivors are expected to have long-term survival. National Cancer 
Centre Singapore (NCCS) is a tertiary centre that treats two-thirds 
of patients in the public sector, with the oncologist-led model being 
the predominant model of survivorship care. Patients may choose 
subsidized care within the public health care network or opt to pay 
out-of-pocket or through insurance claims for private health care.
Previous studies have looked at different cancer survivorship 
models of care, including oncologist-led, oncology nurse-navigator-
led, specialized multidisciplinary clinics or shared-care models (5–7). 
In our proposed shared-care model involving primary care physicians 
(PCPs), an oncologist assumes responsibility for cancer-related care 
with the PCP focussing on primary care. This model adopts a risk-
stratified approach where low-risk breast cancer survivors (BCS) 
are managed by alternating visits with oncologists and PCPs (8). 
Expanding PCPs’ role in survivorship care must go beyond relieving 
oncologists to allow them to focus on active cancer treatment. Indeed, 
there is a recent paradigm shift of focus from ‘fighting the battle 
against cancer’ to ‘living with cancer’ as a chronic disease (9).
Current oncologist-centric follow-up care is associated with 
unmet physical and psychosocial needs (10). BCS grapple with a 
multitude of health needs which range from postsurgical changes, 
cancer-related fatigue, psychological concerns, menopausal symp-
toms, long-term effects of cancer treatment, in addition to cancer 
surveillance. PCPs are best placed to address unmet needs in the psy-
chosocial domains, optimize comorbidities, ensure adherence to life-
style modification and preventive care (11).
We previously conducted a pilot focus group study on private 
PCPs’ perspectives on community-based cancer survivorship care 
in Singapore and found that majority of private PCPs encounter 
very few cancer survivors in their practice (12). They reported bar-
riers like patients’ lack of confidence in primary care, financial con-
straints, limited time and lack of empanelment.
The current study aims to explore the perspectives of PCPs (both 
private and public) towards managing BCS in a community-based 
shared-care programme with oncologists. We limited the discussion 
to the context of patients defined by oncologists as having low-risk 
breast cancer, i.e. cancers with a lower risk of recurrence or death, 
after taking into consideration tumour characteristics, prognostic 
and predictive biomarkers, gene expression profiling and patient-
related factors (13).
Methods
Participants and setting
This study analysed focus groups discussions (FGDs) and in-depth 
interviews (IDIs) data examining PCPs’ perspectives of a shared-
care survivorship concept for BCS. Purposive sampling (14) was 
employed to capture the views of PCPs from a broad range of 
experience, which included private PCPs and public PCPs from 
SingHealth, National Healthcare Group, National University 
Polyclinics in Singapore from June 2018 to November 2018. 
Participants included must be actively practising family medicine 
and be at least 3 years postgraduation. PCPs who practice in non-
family medicine fields or non-community areas (e.g. emergency 
departments, secondary or tertiary care hospitals) were excluded 
from this study.
The key facilitator, R.W.Y.F.  encountered some participants 
through training programmes organized by the College of Family 
Physicians Singapore. Participants from SingHealth Polyclinics were 
recruited by J.H.M.Q., the site principal investigator. Key stake-
holders and institutional leaders from clinical services, education and 
research domains were invited to IDIs to delve deeper into personal 
perceptions. Eighty PCPs were approached by phone or email, three 
did not respond and seven did not participate due to scheduling dif-
ficulties. This accounted for a response rate of 88% (70 PCPs).
Data collection
Eleven FGDs and six IDIs lasting between 30 and 80 minutes were 
facilitated by R.W.Y.F. or A.C., assisted by another coinvestigator. 
Written informed consent was taken before the interviews, which 
were conducted in English within private meeting rooms at NCCS 
or SingHealth Polyclinics. Confidentiality and anonymity were 
maintained by assigning each participant with a serial number and 
deidentifying transcripts. Participants completed an anonymized 
demographic survey before the session.
We utilized a semistructured topic guide adopting a construct-
ivist paradigm, to explore the participants’ perspectives on a broad 
range of ideas (Table 1). The interview guide was pilot tested with 
a focus group comprising of five PCPs, which resulted in minor re-
visions. Each participant was reimbursed with Singapore Dollar 30 
(British Pound 18) for attendance. All sessions were audio-recorded, 
transcribed verbatim and audited by an independent coinvestigator 
(L.L.S.), for accuracy in transcription. The interviews continued until 
data saturation when no new themes emerged (15).
Data analysis
Thematic data analysis (16) was performed with investigators’ 
paying close attention to the data. To maximize reliability, the 
Key Messages
• PCPs acknowledge discrepancy in their current and aspirational role in cancer.
• They are willing to expand their role provided they receive support and training.
• Shared-care empowers PCP and patient, while ensuring sustainable health care cost.
• PCPs recommend role delineation, training, guidelines and care coordination.
• Successful implementation hinges on patient’s conviction in their PCPs’ value.
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transcripts were coded by three independent investigators (Y.K., 
G.Y.L.W., D.Z.W.N.), with two independent analysts per transcript. 
The analysts familiarized with the initial transcripts independently 
and developed a codebook which was applied to the remaining tran-
scripts. The codes were analysed and collated into themes, which 
were reviewed and defined. Coding comparison queries were run 
to identify differences between independent coders and minor dif-
ferences were reconciled upon discussion. The coding process was 
facilitated by the QSR NVivo 12. Member checking was conducted 
and participants were invited to comment on a summary of the 
study findings. Demographic information collected were summar-
ized using descriptive statistics.
Reflexivity
The main facilitator for both FGDs and IDIs was R.W.Y.F. who is an 
experienced female family medicine physician by training, caring for 
low-risk BCS. Another author (A.C.) who facilitated some FGDs is a 
male board-certified specialist pharmacist. Both have substantial ex-
perience in survivorship care at NCCS. The recordings, transcripts, 
coding, field and reflexive notes were maintained in organized secure 
archives, to establish a clear audit trail (17).
Results
Participant characteristics and practice setting
A total of 70 participants took part in eleven FGDs and 6 IDIs 
(Table  2). Majority (84.3%) of participants were Chinese and 
58.6% aged between 30 and 39 years old. Two-thirds (68.6%) have 
5–15 years of clinical practice experience, and 18.6% were highly 
experienced with >20 years’ experience. About 78.6% were public 
PCPs, and 92.9% were utilizing full or partial electronic records.
Approximately two-thirds (64.3%) of the participants experi-
enced heavy patient loads, seeing more than 600 patients monthly. 
Majority of participants (62.9%) had short consultation times with 
only 5–10 minutes per patient visit.
The participants had a low level of engagement with cancer-
related issues, with 62.9% seeing up to 10 BCS monthly. 95.7% 
Table 1. Guiding questions used in FGDs and IDIs held in 2018
Themes Questions
Background survey on current 
practice
Can you share with us some of your 
experience(s) with cancer survivors?
Discuss the perceived barriers 
of the proposed shared-care 
model
What are some of the barrier(s) that 
you can foresee with this shared-care 
model—patient related, physician re-
lated and health care system related?
Gather feedback on the Sur-
vivorship Care Plan (SCP) 
to facilitate communications 
planning
What information should be included 
in the SCP?
Explore some of the motiv-
ations for participation in the 
shared-care model
What are some of your motivation(s) 
to participate in this shared-care 
model?
Relationship with stakeholders Who do you think are or should 
be stakeholders in this shared-care 
model, and possible barrier(s) that 
affect communication and seamless 
coordination and transition of care?
Community resources Who are the community resources 
available and whom we can engage/ 
refer for effective shared-care?
Table 2. Participants’ demographics and characteristics (2018)
Characteristic n (%)
Demographic
 Gender
  Male 34 (48.6%)
  Female 36 (51.4%)
 Ethnicity
  Chinese 59 (84.3%)
  Indian 7 (10.0%)
  Others 4(5.7%)
 Practice experience (years)
  <5 4 (5.7%)
  5–10 30 (42.9%)
  11–15 18 (25.7%)
  16–20 5 (7.1%)
  >20 13 (18.6%)
 Age (years)
  20–29 5 (7.1%)
  30–39 41 (58.6%)
  40–49 14 (20.0%)
  50–59 10 (14.3%)
Practice setting
 Current practice setting
  Public 55 (78.6%)
  Private general practitioner 15 (21.4%)
 Practice area
  North 10 (14.3%)
  South 15 (21.4%)
  East 11 (15.7%)
  West 10 (14.3%)
  Central 24 (34.3%)
 Types of medical records
  Paper records 5 (7.1%)
  Partial/ in transition 5 (7.1%)
  Full electronic records 60 (85.8%)
Current experience with patients
 Average number of patients seen monthly
  <300 7 (10.0%)
  300–400 6 (8.6%)
  401–500 3 (4.3%)
  501–600 9 (12.9%)
  >600 45 (64.3%)
 Average amount of time spent with each patient (minutes)
  <5 1 (1.4%)
  5–10 44 (62.9%)
  11–15 21 (30.0%)
  16–20 3 (4.3%)
  >20 1 (1.4%)
 Average number of cancer survivors seen monthly
  <5 23 (32.9%)
  5–10 21 (30.0%)
  11–15 15 (21.4%)
  16–20 2 (2.9%)
  >20 9 (12.9%)
 Time spent caring for cancer survivors care on cancer-related issues 
(% of total consultation time spent in practice)
  <20 67 (95.7%)
  20–50 3 (4.3%)
  >50 0 (0%)
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of participants spent less than 20% of their total consultation time 
caring for cancer-related issues.
Two major themes emerged, which were roles of PCPs and re-
commendations for the shared-care model.
Roles of PCPs
Current role
 The current role of PCPs is mainly limited to acute, non-cancer-
related issues. Areas PCPs have done well include optimal care for 
comorbidities, health promotion and preventive care. Their existing 
relationship and rapport with BCS can impact behavioural change 
and address psychosocial issues like anxiety, depression and mood 
disorders.
(PCPs) have a bit of advantage in swaying them (BCS) to improve 
their disease…we are definitely more trained in terms of psy-
chological issues…Because it happens with chronic illness also. 
FGD#41, public
Aspirational role
 PCPs aspired to expand their role to include cancer surveillance, 
risk assessment and addressing unmet psychosocial needs in the 
cancer domain. PCPs preferred to harmonize cancer survivorship 
management of their primary care patients who are also BCS. 
PCPs indicated the need to have a distinct role for PCPs in this 
shared-care model.
we (PCPs can) keep a lookout if they (BCS) develop some acute 
complaints, for example, chronic cough or back pain, we will be a 
bit more proactive in doing further investigations to rule out any 
cancer recurrence. FGD#3, public
PCPs hope to address psychological barriers of BCS for transition 
and reintegration back into society; either to return to work or their 
previous social role.
Constraints and motivations behind the role
 PCPs encounter constraints in this aspirational role and are unclear 
of the demarcation of their responsibility in this shared-care model. 
They are concerned about the increased workload imposed on their 
busy practice.
Despite this, PCPs believe in the value of shared-care in providing 
accessible care for an increasing population of cancer survivors. 
Shared-care promotes patient autonomy, supports empowerment 
and encourages ownership. Furthermore, it shifts the focus from 
disease-specific to patient-centric care and encourages specificity in 
the physician–patient relationship.
So, I think it’s actually good, I mean, it’s IDEAL if the patient has 
ONE primary care physician to follow up with, providing this 
patient with continuous and holistic care, and you are actually 
bridging the gap between tertiary care and (the) transition back 
to primary care. FGD#2, public
From the physicians’ perspective, shared-care allows PCPs to pro-
vide comprehensive care and opportunity to widen their skill set and 
enhance their capabilities. To the health care system, shared-care 
promotes right-siting of patients to the community, alleviating strain 
on tertiary care.
Recommendations for shared-care
Patient selection and trust
 PCPs should select BCS from their current pool of primary care 
patients whom they are already seeing for chronic conditions. The 
existing therapeutic doctor–patient relationship can be maintained, 
and BCS’ trust and confidence in their PCPs could be strengthened to 
manage both cancer and non-cancer-related issues throughout their 
journey.
they (BCS) came from us in the first place, …perhaps we (PCPs) 
are the ones who pick up a breast lump, we refer them, or maybe 
if it’s one of our chronic patients, she’s known to us, …these types 
of patients will be the better ones to decant back, because the trust 
is already built, and they are familiar with us. FGD#51, public
Another enabler is for oncologists to stratify and select BCS with a 
low risk for cancer recurrence and stabilized health issues. Patients 
selected should be mutually agreed on by oncologists and PCPs.
I(PCP) reiterate the point that active issue(s) should be resolved 
because it’s very difficult for us primary care to manage the ac-
tive issues at one time. (For) minor adjustments, we will make, 
once there’s variation. So, the general principle (here) is (a) minor 
issue, maintenance issue, and (whether) we can build a relation-
ship, then we can refer back, get back into the system in case there 
are problems. IDI#1, public
Equipping PCPs with skills and knowledge, demarcation of 
roles and responsibilities
PCPs recognized their limitations in knowledge and experience in 
cancer care, with the rapid advancements in oncology. They called 
attention to their lack of training and confidence, thus recom-
mending clinical attachments at NCCS to observe specialists’ clinical 
and communication skills.
Training doesn’t need to be very deep, like, extensive. It just means 
that you need the means (to handle) common everyday problems 
that occur in the context of cancer survivorship. FGD#16, private
The exposure would enable PCPs to appreciate the multiple needs 
of survivors and their management strategies. The design of the 
training programme should identify and target PCPs’ knowledge 
gaps and deliver sufficient information without overloading PCPs.
Mutually agreed demarcation of roles and responsibilities is crit-
ical. Oncologists should manage recurrence and long-term side ef-
fects of cancer treatment, while PCPs focus on health maintenance, 
preventive care and identifying red flags suggestive of recurrence for 
prompt referral to the oncologists.
Enhance infrastructure support
 To address the barrier of limited consultation time, public PCPs re-
commended care of BCS to be initiated at Family-Physician Clinics. 
These clinics are run by public PCPs with postgraduate family medi-
cine training, which focusses on delivering patient-centric care and 
allows extended consultation time for managing patients with com-
plex care. PCPs reiterated the need for sustainable financial resources 
and timely communication. A defined survivorship care plan should 
be incorporated into the shared electronic medical record (EMR) 
with updated practice guidelines, dynamic care templates and work-
flow prompts.
a whole programme, not just the training…, but the informa-
tion flow, the support, the resourcing, the referring-back mech-
anism…, good follow-up programme, and obviously there must 
be resources and capability to manage that. IDI#1, public
a digitalised form and there can be constant updates…, two-
way communication where what we wrote can be seen by the on-
cologists and the oncologists’ (notes) can be seen by us. FGD#62, 
private
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Care coordinators, proficient in accessing community resources, are 
essential to facilitate proper handover and ensure smooth transition 
of care.
Discussion
Key findings in our study include PCPs’ willingness to expand their 
current role to include cancer surveillance, risk assessment and ad-
dressing unmet psychosocial needs in the cancer domain. This dis-
crepancy between current and aspirational/desired role was also 
reported by family physicians in Canada, which they felt was hin-
dered by patient-based, system and professional barriers (18). We pro-
posed to use a patient-centric care approach to help us conceptualize 
the recommendations of the participants, which were derived from 
the themes of the study (Fig. 1). A similar strategy was described by 
studies to incorporate risk stratification, clarity of roles, timely com-
munication, care coordination and clear routes for access back to 
specialist care (19,20). A multifaceted training programme, evidence-
based guidelines for common survivorship issues and updated care 
plans are essential components of high-quality survivorship care and 
are gradually being adopted into routine services in Australia (21).
The added value of this larger study provided opportunities to 
explore and understand the different challenges and needs between 
private and public settings. The recommendations can be imple-
mented on a national level (e.g. policy change to enhance financial 
reimbursement to private PCPs and develop an accessible/integrated 
training programme) or at different practice settings (e.g. team-based 
care in public polyclinics and linking up private PCPs into primary 
care networks to share resources).
Private PCPs, who are self-funded proposed for policymakers to 
recognize cancer as a chronic disease to allow BCS to leverage on 
the current chronic disease care support system (22). This will lower 
out-of-pocket cost for survivorship care. In contrast, public PCPs 
receive direct funding from the government to deliver subsidized 
primary care supported by multidisciplinary primary health care 
professionals. As a result of the health care financing policy in 
Singapore, the bulk of chronic disease management is handled by 
public PCPs. As BCS age, many of them develop chronic medical 
conditions. The polyclinics are thus ideal sites for the holistic man-
agement of BCS (Table 3).
PCPs are well-positioned to provide holistic patient-centric care 
in view of their accessibility and broad-based training. Randomized 
trials have demonstrated similar recurrence detection rates, health 
outcomes (23) and better patient satisfaction when follow-up is done 
by PCPs (24). Survivors acknowledged the importance of having their 
PCPs involved in follow-up care (25). This is especially important 
Figure 1. Roles and recommendations derived from study themes for shared-care in BCS.
Table 3. Main differences in health care structure between public and private PCPs in Singapore
Public PCPs Private PCPs
Financing system •  Government subsidy for all eligible patients (citizens 
and permanent residents) and covers all medical  
conditions
• Fee-for-service for most patients
•  Portable subsidies (Community Health Assist Scheme) for eligible 
patients. Maximum allocated for current approved chronic  
medical conditions is $540 Sing Dollar per year (302 British 
pound sterling) and selected dental services
Infrastructure •  Larger, multidoctor team-based care supported by 
nurses, allied health, pharmacists, on-site laboratory, 
radiology and sometimes dentists
•  Solo practice or group clinic with a few doctors. Referral to  
private laboratories or radiological services as indicated
•  Universal use of EMR and access to National  
Electronic Health Record (NEHR)
•  Optional participation in Primary Care Networks
•  Optional use of EMR and access to National Electronic Health 
Record (NEHR)
Education and 
training
•  Family medicine residency training •  Optional site for clinic attachment for family medicine 
training programmes•  Regular continuing medical education
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for those with comorbidities affecting medical decision-making, 
health outcomes and quality of life (26). Cancer survivors are at in-
creased risk for cardiovascular diseases, both as a result of cancer 
therapies and shared cardiovascular risk factors like obesity, in-
activity, smoking and poor diet (27,28). Traditional cardiovascular 
risk prediction tools do not include cancer as a risk factor. Thus, it is 
imperative for PCPs to recognize the association and advocate risk 
reduction strategies, especially for older BCS (29).
Studies have shown that PCPs are more adept in providing psycho-
social support and behavioural modification (30,31). Furthermore, 
PCPs have a long-standing relationship with their patient and family, 
which can promote and sustain behavioural changes like smoking 
cessation, exercise and weight maintenance. Participants in our 
study were confident in delivering health promotion and preventive 
care, which have been linked to improved outcomes (32).
PCPs in our study acknowledged their limited knowledge and 
lack of confidence in cancer care, a similar finding among PCPs over-
seas (33). In recent years, training in cancer survivorship for PCPs 
worldwide has undergone rapid progress; with online courses, re-
source toolkits and continuing medical education. American Society 
of Clinical Oncology has developed a core curriculum and compe-
tencies targeting health care practitioners for cancer survivorship 
education (34). In contrast, Singapore’s current education outreach 
lacks coordination and structure. PCPs in our study recommended 
the development of local clinical practice guidelines and adoption of 
a multifaceted education and training programme to cover preven-
tion, early detection and survivorship.
Studies recognized the value of a positive working relationship 
between PCPs and specialists to support shared-care. This can be 
achieved by care coordinators engaging and keeping PCPs ‘in the 
loop’ (35,36). Most PCPs in our study have access and agreed that a 
centralized EMR could be a viable platform to support the routine 
usage of a web-based survivorship care plan to guide patient care 
and facilitate communication.
There are existing shared-care programmes for cancer survivors 
in Canada, Denmark, Australia, but not in Singapore. Overall, 
shared-care is highly acceptable, resulting in better patient compli-
ance and satisfaction. In terms of effectiveness, shared-care has been 
shown to be similar to usual care (37,38). The current findings and 
recommendations of this study have implications for the integration 
of a shared-care model into routine primary care practice. Shared-
care should be initiated early to establish a relationship among the 
various stakeholders. Once stable, BCS can be discharged completely 
back to their PCPs upon completion of endocrine therapy.
Several limitations of this study should be considered. Firstly, 
PCPs who participated may have a special interest in survivorship 
care and may not be representative of all PCPs. To minimize the im-
pact of this limitation, we recruited a large number of participants 
from diverse practice settings and conducted FGDs/IDIs to provide 
a broad range of viewpoints. Secondly, we did not include BCS and 
specialists in this study, although we had described their perceptions 
and barriers in previous publications (39,40). Our next study will 
include different stakeholders to assess feasibility, adherence and 
cost-effectiveness of this shared-care model. Thirdly, although our 
results may not be generalizable to all PCPs or other cancer types, 
they can apply to PCPs who practise in a similar health care system 
caring for low-risk BCS.
Conclusions
PCPs in Singapore are willing to share the care of low-risk BCS 
with oncologists. Recommendations from PCPs included risk 
stratification, role definition, focussed training, viable care pathways, 
practice guidelines, timely communication and sustainable funding 
to equip them for this expanded role. However, the successful im-
plementation of a shared-care programme must be centred around 
instilling in the BCS the belief that her PCP is a valued partner in her 
cancer journey.
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